AusPAR: Insulin aspart

Australian Public Assessment Report

AusPAR

AusPAR: Insulin aspart [PDF, 516.6 KB]

AusPAR: Insulin aspart [Word, 754.52 KB]

Attachment: Product Information for Insulin aspart [PDF, 249.43 KB]

Attachment: Product Information for Insulin aspart [Word, 233.58 KB]

Device/Product Name

Truvelog

Active ingredients

Insulin aspart

AusPAR Date

1 March 2021

Published

19 March 2021

Submission Number

PM-2019-04815-1-5

Submission Type

New biosimilar medicine

Decision

Approved